The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mckenna Mark C. since 2019.
This trader's CIK number is 1749623.
At the time of last reporting, Mckenna Mark C. was the Officer of Apogee Therapeutics, Inc.. (stock ticker symbol APGE).
Also see all insider trading activities at Apogee Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | RXDX | 0 | $0 | 125,000 | $14,988,430 | 247,531 | $684,321 |
2021 | RXDX | 0 | $0 | 0 | $0 | 15,400 | $44,660 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | APGE | 20,000 | $988,700 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | BHC | 0 | $0 | 10,773 | $235,217 | 0 | $0 |
1. Prometheus Biosciences, Inc. (RXDX)
2. Apogee Therapeutics, Inc. (APGE)
3. Bausch Health Companies Inc. (BHC)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-06-02 | RXDX | Option Ex | 122,531 | 2.30 | 281,821 |
2023-03-15 | RXDX | Option Ex | 25,000 | 2.90 | 72,500 |
2023-03-15 | RXDX | Sale | 25,000 | 116.14 | 2,903,500 |
2023-03-01 | RXDX | Option Ex | 700 | 3.70 | 2,590 |
2023-03-01 | RXDX | Sale | 700 | 125.26 | 87,682 |
2023-03-03 | RXDX | Option Ex | 10,620 | 3.70 | 39,294 |
2023-03-03 | RXDX | Sale | 10,620 | 125.13 | 1,328,880 |
2023-02-15 | RXDX | Option Ex | 25,000 | 2.90 | 72,500 |
2023-02-16 | RXDX | Option Ex | 25,000 | 3.70 | 92,500 |
2023-02-15 | RXDX | Sale | 25,000 | 119.42 | 2,985,500 |
2023-02-17 | RXDX | Option Ex | 13,680 | 3.70 | 50,616 |
2023-02-16 | RXDX | Sale | 25,000 | 119.87 | 2,996,750 |
2023-02-17 | RXDX | Sale | 13,680 | 125.10 | 1,711,368 |
2023-01-17 | RXDX | Option Ex | 25,000 | 2.90 | 72,500 |
2023-01-17 | RXDX | Sale | 25,000 | 118.99 | 2,974,750 |
2021-12-01 | RXDX | Option Ex | 15,400 | 2.90 | 44,660 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-12-12 | APGE | Buy | 20,000 | 49.44 | 988,700 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-08-19 | BHC | Sale | 10,773 | 21.83 | 235,217 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mckenna Mark C. (Officer of Apogee Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.